Then we further manipulated CCBE1 expression levels with RNA interference or treatment with recombinant CCBE1 protein, and found both of modulation exerted significant influence on GIST-T1 response to imatinib. This evidence concerns the gene CCBE1 and gastrointestinal stromal tumor.